BUZZ-Rocket Pharmaceuticals falls after upsized $165 mln stock offering

Reuters12-11
BUZZ-Rocket Pharmaceuticals falls after upsized $165 mln stock offering

** Shares of gene therapy developer Rocket Pharmaceuticals RCKT.O fall 3.9% to $12.98 premarket

** RCKT sold 13.2 mln shares in an upsized public offering at $12.50/shr for gross proceeds of $165 mln

** Offering size was boosted from the $150 mln worth of shares announced on Tuesday, priced at a 7.5% discount to stock's last close of $13.51

** Additionally, on Tuesday, life sciences investment firm RTW had agreed to purchase pre-funded warrants representing the right to purchase $5 mln worth of RCKT shares in a concurrent private placement

** Morgan Stanley, Leerink Partners and Cantor were the joint book-running managers for the offering

** RCKT had 91.2 mln outstanding shares as of Sept. 30, according to an SEC filing, giving it a $1.23 bln market capitalization as of most recent closing price

** As of last close, RCKT shares down 54.9% YTD

(Reporting by Arasu Kannagi Basil in Bengaluru)

((ArasuKannagi.Basil@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment